Recombinant influenza A viruses as vaccine vectors.

Authors:
Thomas Gerlach
Thomas Gerlach
Robert Koch-Institute
Husni Elbahesh
Husni Elbahesh
St. Jude Children's Research Hospital
United States
Giulietta Saletti
Giulietta Saletti
University of Bologna
Italy
Guus F Rimmelzwaan
Guus F Rimmelzwaan
Erasmus Medical Center
Netherlands

Expert Rev Vaccines 2019 Apr 4;18(4):379-392. Epub 2019 Mar 4.

a Research Center for Emerging Infections and Zoonoses (RIZ) , University of Veterinary Medicine Hannover (TiHo) , Hannover , Germany.

Introduction: Various viruses, including poxviruses, adenoviruses and vesicular stomatitis virus, have been considered as vaccine vectors for the delivery of antigens of interest in the development of vaccines against newly emerging pathogens. Areas covered: Here, we review results that have been obtained with influenza A viruses (IAV) as vaccine vectors. With the advent of reverse genetics technology, IAV-based recombinant vaccine candidates have been constructed that induce protective immunity to a variety of different pathogens of interest, including West Nile virus, Plasmodium falciparum and respiratory syncytial virus. The various cloning strategies to produce effective and attenuated, safe to use IAV-based viral vectors are discussed. Expert commentary: It was concluded that IAV-based vector system has several advantages and holds promise for further development.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14760584.2019.1582338DOI Listing
April 2019
10 Reads

Publication Analysis

Top Keywords

vaccine vectors
12
influenza viruses
8
interest including
4
pathogens interest
4
variety pathogens
4
protective immunity
4
immunity variety
4
including west
4
plasmodium falciparum
4
virus plasmodium
4
nile virus
4
west nile
4
induce protective
4
candidates constructed
4
advent reverse
4
vectors advent
4
iav vaccine
4
viruses iav
4
reverse genetics
4
genetics technology
4

References

(Supplied by CrossRef)

Similar Publications